Biosimilar Monoclonal Antibodies Market by Type by Drug Class by Region - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018–2026
Biosimilar monoclonal antibodies (mAbs) are intricate, large type of proteins of the biosimilar family used by the immune system to recognize and counterbalance the foreign bodies, such as bacteria, viruses and others. These antibodies are usually managed in the treatment of diseases such as rheumatoid arthritis, hodgkins lymphoma, chronic lymphocytic leukemia and others. These antibodies are produced by using undistinguishable immune cells that are clones of one exclusive parent cell, all monoclonal antibodies produced by the parent cell are the...
View full press release